BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23694763)

  • 1. Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway.
    Li H; Yang B; Huang J; Xiang T; Yin X; Wan J; Luo F; Zhang L; Li H; Ren G
    Toxicol Lett; 2013 Jul; 220(3):219-28. PubMed ID: 23694763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.
    Benatar T; Yang W; Amemiya Y; Evdokimova V; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2012 Jun; 133(2):563-73. PubMed ID: 21997538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway.
    Li H; Huang J; Yang B; Xiang T; Yin X; Peng W; Cheng W; Wan J; Luo F; Li H; Ren G
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):180-90. PubMed ID: 23707762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
    Zhao L; Miao HC; Li WJ; Sun Y; Huang SL; Li ZY; Guo QL
    Mol Carcinog; 2016 May; 55(5):778-92. PubMed ID: 25945460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
    Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
    Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flavonoid Baohuoside-I inhibits cell growth and downregulates survivin and cyclin D1 expression in esophageal carcinoma via β-catenin-dependent signaling.
    Wang L; Lu A; Liu X; Sang M; Shan B; Meng F; Cao Q; Ji X
    Oncol Rep; 2011 Nov; 26(5):1149-56. PubMed ID: 21785828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
    Yadav B; Taurin S; Larsen L; Rosengren RJ
    Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naringin induces endoplasmic reticulum stress-mediated apoptosis, inhibits β-catenin pathway and arrests cell cycle in cervical cancer cells.
    Lin R; Hu X; Chen S; Shi Q; Chen H
    Acta Biochim Pol; 2020 Apr; 67(2):181-188. PubMed ID: 32343512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
    Kuo PL; Chen CY; Hsu YL
    Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid inhibited the Wnt/β-catenin pathway and suppressed breast cancer cells in vitro and in vivo.
    Xue M; Wang Q; Zhao J; Dong L; Ge Y; Hou L; Liu Y; Zheng Z
    J Nutr Biochem; 2014 Feb; 25(2):104-10. PubMed ID: 24290517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells.
    Lee EJ; Oh SY; Sung MK
    Food Chem Toxicol; 2012 Nov; 50(11):4136-43. PubMed ID: 22926442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
    Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling.
    Hsieh TH; Hsu CY; Tsai CF; Chiu CC; Liang SS; Wang TN; Kuo PL; Long CY; Tsai EM
    Sci Rep; 2016 Jan; 6():19156. PubMed ID: 26750754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
    Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
    Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.